Logo image of PRM

PERIMETER SOLUTIONS INC (PRM) Stock Fundamental Analysis

NYSE:PRM - US71385M1071 - Common Stock

19.48 USD
+0.79 (+4.23%)
Last: 8/22/2025, 8:04:01 PM
19.48 USD
0 (0%)
After Hours: 8/22/2025, 8:04:01 PM
Fundamental Rating

5

Taking everything into account, PRM scores 5 out of 10 in our fundamental rating. PRM was compared to 84 industry peers in the Chemicals industry. PRM has only an average score on both its financial health and profitability. PRM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

PRM had negative earnings in the past year.
In the past year PRM had a positive cash flow from operations.
In multiple years PRM reported negative net income over the last 5 years.
PRM had a positive operating cash flow in 4 of the past 5 years.
PRM Yearly Net Income VS EBIT VS OCF VS FCFPRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.54%, PRM belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
With a decent Return On Equity value of 10.96%, PRM is doing good in the industry, outperforming 77.38% of the companies in the same industry.
PRM's Return On Invested Capital of 5.05% is in line compared to the rest of the industry. PRM outperforms 57.14% of its industry peers.
Industry RankSector Rank
ROA 5.54%
ROE 10.96%
ROIC 5.05%
ROA(3y)2.14%
ROA(5y)-3.4%
ROE(3y)4.47%
ROE(5y)-7.84%
ROIC(3y)N/A
ROIC(5y)N/A
PRM Yearly ROA, ROE, ROICPRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

PRM's Profit Margin of 23.23% is amongst the best of the industry. PRM outperforms 100.00% of its industry peers.
Looking at the Operating Margin, with a value of 25.94%, PRM belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
The Gross Margin of PRM (56.54%) is better than 98.81% of its industry peers.
PRM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 25.94%
PM (TTM) 23.23%
GM 56.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.47%
GM growth 5Y10.02%
PRM Yearly Profit, Operating, Gross MarginsPRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRM is destroying value.
Compared to 1 year ago, PRM has more shares outstanding
The number of shares outstanding for PRM has been reduced compared to 5 years ago.
Compared to 1 year ago, PRM has an improved debt to assets ratio.
PRM Yearly Shares OutstandingPRM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
PRM Yearly Total Debt VS Total AssetsPRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.68, we must say that PRM is in the distress zone and has some risk of bankruptcy.
PRM's Altman-Z score of 1.68 is in line compared to the rest of the industry. PRM outperforms 42.86% of its industry peers.
The Debt to FCF ratio of PRM is 4.14, which is a neutral value as it means it would take PRM, 4.14 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.14, PRM belongs to the top of the industry, outperforming 82.14% of the companies in the same industry.
PRM has a Debt/Equity ratio of 0.65. This is a neutral value indicating PRM is somewhat dependend on debt financing.
The Debt to Equity ratio of PRM (0.65) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.14
Altman-Z 1.68
ROIC/WACC0.58
WACC8.67%
PRM Yearly LT Debt VS Equity VS FCFPRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

PRM has a Current Ratio of 5.23. This indicates that PRM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.23, PRM belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
A Quick Ratio of 3.56 indicates that PRM has no problem at all paying its short term obligations.
The Quick ratio of PRM (3.56) is better than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 5.23
Quick Ratio 3.56
PRM Yearly Current Assets VS Current LiabilitesPRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.00% over the past year.
The Revenue has grown by 74.16% in the past year. This is a very strong growth!
The Revenue has been growing by 18.58% on average over the past years. This is quite good.
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%178.57%
Revenue 1Y (TTM)74.16%
Revenue growth 3Y15.69%
Revenue growth 5Y18.58%
Sales Q2Q%27.78%

3.2 Future

The Earnings Per Share is expected to grow by 50.43% on average over the next years. This is a very strong growth
Based on estimates for the next years, PRM will show a small growth in Revenue. The Revenue will grow by 3.27% on average per year.
EPS Next Y210.43%
EPS Next 2Y80.39%
EPS Next 3Y50.43%
EPS Next 5YN/A
Revenue Next Year-0.32%
Revenue Next 2Y2.48%
Revenue Next 3Y3.27%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PRM Yearly Revenue VS EstimatesPRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
PRM Yearly EPS VS EstimatesPRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

5

4. Valuation

4.1 Price/Earnings Ratio

PRM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
PRM is valuated rather expensively with a Price/Forward Earnings ratio of 17.07.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PRM is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.82, PRM is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 17.07
PRM Price Earnings VS Forward Price EarningsPRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRM indicates a slightly more expensive valuation: PRM is more expensive than 63.10% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PRM indicates a somewhat cheap valuation: PRM is cheaper than 78.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.1
EV/EBITDA 15.57
PRM Per share dataPRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of PRM may justify a higher PE ratio.
A more expensive valuation may be justified as PRM's earnings are expected to grow with 50.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y80.39%
EPS Next 3Y50.43%

0

5. Dividend

5.1 Amount

No dividends for PRM!.
Industry RankSector Rank
Dividend Yield N/A

PERIMETER SOLUTIONS INC

NYSE:PRM (8/22/2025, 8:04:01 PM)

After market: 19.48 0 (0%)

19.48

+0.79 (+4.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners84.97%
Inst Owner Change3%
Ins Owners8.61%
Ins Owner Change4.76%
Market Cap2.85B
Analysts80
Price Target19.38 (-0.51%)
Short Float %3.3%
Short Ratio3.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)206.27%
Min EPS beat(2)98.02%
Max EPS beat(2)314.52%
EPS beat(4)3
Avg EPS beat(4)260%
Min EPS beat(4)-196.63%
Max EPS beat(4)824.09%
EPS beat(8)6
Avg EPS beat(8)194.95%
EPS beat(12)9
Avg EPS beat(12)162.36%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.98%
Min Revenue beat(2)-4.91%
Max Revenue beat(2)10.87%
Revenue beat(4)2
Avg Revenue beat(4)12.23%
Min Revenue beat(4)-4.91%
Max Revenue beat(4)43.99%
Revenue beat(8)5
Avg Revenue beat(8)16.22%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.63%
PT rev (3m)15.63%
EPS NQ rev (1m)15.22%
EPS NQ rev (3m)12.77%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)32.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.07
P/S 5.01
P/FCF 15.1
P/OCF 13.75
P/B 2.37
P/tB N/A
EV/EBITDA 15.57
EPS(TTM)-0.06
EYN/A
EPS(NY)1.14
Fwd EY5.86%
FCF(TTM)1.29
FCFY6.62%
OCF(TTM)1.42
OCFY7.27%
SpS3.89
BVpS8.23
TBVpS-4.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.54%
ROE 10.96%
ROCE 6.39%
ROIC 5.05%
ROICexc 5.52%
ROICexgc 57.84%
OM 25.94%
PM (TTM) 23.23%
GM 56.54%
FCFM 33.2%
ROA(3y)2.14%
ROA(5y)-3.4%
ROE(3y)4.47%
ROE(5y)-7.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.47%
GM growth 5Y10.02%
F-Score8
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.14
Debt/EBITDA 3.66
Cap/Depr 28.39%
Cap/Sales 3.27%
Interest Coverage 4.01
Cash Conversion 97.32%
Profit Quality 142.91%
Current Ratio 5.23
Quick Ratio 3.56
Altman-Z 1.68
F-Score8
WACC8.67%
ROIC/WACC0.58
Cap/Depr(3y)17.09%
Cap/Depr(5y)16.01%
Cap/Sales(3y)2.7%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%178.57%
EPS Next Y210.43%
EPS Next 2Y80.39%
EPS Next 3Y50.43%
EPS Next 5YN/A
Revenue 1Y (TTM)74.16%
Revenue growth 3Y15.69%
Revenue growth 5Y18.58%
Sales Q2Q%27.78%
Revenue Next Year-0.32%
Revenue Next 2Y2.48%
Revenue Next 3Y3.27%
Revenue Next 5YN/A
EBIT growth 1Y214.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.48%
EBIT Next 3Y15.58%
EBIT Next 5YN/A
FCF growth 1Y1889.27%
FCF growth 3Y40.29%
FCF growth 5YN/A
OCF growth 1Y23622.2%
OCF growth 3Y37.57%
OCF growth 5YN/A